DIN 02502445 — INREBIC 100 MG
INREBIC is a capsule of Fedratinib marketed by BRISTOL-MYERS SQUIBB CANADA. The full Fedratinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02502445
- Brand name
- INREBIC
- Active ingredient
- Fedratinib
- Strength
- 100 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Janus kinase 2 (JAK2) inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.